ISPE Highlights
Pharmaceutical Engineering Magazine
Highlights From ISPE Knowledge Network
- Good Practice Guide: SMEPAC - Standardized Methodology for the Evaluation of Pharma Airborne Particle Emissions from Containment Systems 3rd Edition
- 2024 FOYA Banquet Recap: Celebrating Excellence and Tips for Submitting to the 2025 Facility of the Year Awards
- Process Considerations When Designing mAbs Production Facilities
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Unlock the Future of Pharmaceutical Manufacturing: Learn from Industry Leaders at the 2024 ISPE Pharma 4.0™ and Annex 1 Conference
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Overcoming Fear of the Engineer-Procure-Construct (EPC) Model to Recognize Project Execution Benefits
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Explore the Possibilities of Pharmaceutical Advancement with Digital Tools, Including AI/ML at the 2024 ISPE Annual Meeting & Expo
- Good Practice Guide: SMEPAC - Standardized Methodology for the Evaluation of Pharma Airborne Particle Emissions from Containment Systems 3rd Edition
- 2024 FOYA Banquet Recap: Celebrating Excellence and Tips for Submitting to the 2025 Facility of the Year Awards
- Process Considerations When Designing mAbs Production Facilities
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Unlock the Future of Pharmaceutical Manufacturing: Learn from Industry Leaders at the 2024 ISPE Pharma 4.0™ and Annex 1 Conference
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Overcoming Fear of the Engineer-Procure-Construct (EPC) Model to Recognize Project Execution Benefits
- Process Considerations When Designing mAbs Production Facilities
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Post Approval Changes and ICH Q12
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Post Approval Changes and ICH Q12
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Explore the Possibilities of Pharmaceutical Advancement with Digital Tools, Including AI/ML at the 2024 ISPE Annual Meeting & Expo
Explore the benefits of ISPE membership.